Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.255 USD | +1.21% | +8.19% | -2.71% |
Business Summary
Number of employees: 1,573
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
So-Young
82.1
%
| 151 | 80.9 % | 174 | 82.1 % | +14.98% |
Wuhan Miracle
17.9
%
| 36 | 19.3 % | 38 | 17.9 % | +5.40% |
Elimination
-0.1
%
| 0 | -0.1 % | 0 | -0.1 % | -23.85% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 187 | 100.0 % | 211 | 100.0 % | +13.19% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Xing Jin
CEO | Chief Executive Officer | 44 | 01/13/01 |
Hui Zhao
DFI | Director of Finance/CFO | - | - |
Xiaodong Ying
BRD | Director/Board Member | - | - |
Nan Huang
HRO | Human Resources Officer | 41 | 01/21/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Hai Peng Zhang
BRD | Director/Board Member | 48 | 05/19/05 |
Xing Jin
CEO | Chief Executive Officer | 44 | 01/13/01 |
Nan Shen
BRD | Director/Board Member | 39 | 12/23/12 |
Chao He
BRD | Director/Board Member | 65 | 01/20/01 |
Xiaodong Ying
BRD | Director/Board Member | - | - |
Hui Zhao
DFI | Director of Finance/CFO | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 30 | 12,000,000 | 0 | 0 | 61.59 % |
Stock B | 1 | 73,688,044 | 52,773,809 ( 71.62 %) | 9,819,124 ( 13.33 %) |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
CUTIA THERAPEUTICS 0.12% | 357,800 | 0.12% | 360,705 $ |
Company contact information
Sector
Sales per Business
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.71% | 123M | |
+19.07% | 414B | |
+15.27% | 242B | |
+20.63% | 104B | |
+17.19% | 83.87B | |
+54.11% | 57.64B | |
+33.59% | 53.37B | |
+6.02% | 37.83B | |
+15.88% | 34.11B | |
-8.32% | 23.18B |
- Stock Market
- Equities
- SY Stock
- Company So-Young International Inc.